Anti-RUNX2 antibody [EPR14334] (Ab192256)
AML3, CBFA1, OSF2, PEBP2A, RUNX2, Runt-related transcription factor 2, Acute myeloid leukemia 3 protein, Core-binding factor subunit alpha-1, Oncogene AML-3, Osteoblast-specific transcription factor 2, Polyomavirus enhancer-binding protein 2 alpha A subunit, SL3-3 enhancer factor 1 alpha A subunit, SL3/AKV core-binding factor alpha A subunit, CBF-alpha-1, OSF-2, PEA2-alpha A, PEBP2-alpha A
详细信息
特异性
Below the target band, there are multi bands may be caused by protein degradation. We suggest customer to use freshly lysate to minimize protein degradation in western blot.
背景信息
Product Specifications Anti-RUNX2 antibody [EPR14334] (ab192256) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P and WB in human, mouse and rat samples. Anti-RUNX2 antibody [EPR14334] (ab192256) specifically detects RUNX2 (UniProt ID: Q13950; Molecular weight: 57kDa) and is sold in 100 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-RUNX2 antibody [EPR14334] (ab192256) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-RUNX2 antibody [EPR14334] (ab192256) has been cited over 114 times in peer reviewed journals and is trusted by the scientific community. Anti-RUNX2 antibody [EPR14334] (ab192256) has 8 independent reviews from customers. Related Products Antibody clone EPR14334 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647 ( ab215954, ab215955 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (212)
Stromal vascular fraction self-assembles vascularized osteogenic organoids with immunomodulatory functions.
基质血管成分可自组装形成具有免疫调节功能的血管化成骨类器官。
Composite hydrogel-microsphere delivery system promotes early nerve-mediated bone regeneration and late-stage mechanotransduction-driven bone remodeling via sequential release of NGF and Yoda1.
复合水凝胶-微球递送系统通过依次释放 NGF 和 Yoda1,促进早期神经介导的骨再生和晚期机械转导驱动的骨重塑。
Identification of ephrin-A1-EphA2 signalling as a potential target for fracture prevention.
确定 Ephrin-A1-EphA2 信号通路是预防骨折的潜在靶点。
Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice.
因子 VIII 可恢复因子 VIII 敲除雄性小鼠的骨骼参数并调节肌肉蛋白质代谢组。
CGRP Enhances the Regeneration of Bone Defects by Regulating Bone Marrow Mesenchymal Stem Cells Through Promoting ANGPTL4 Secretion by Bone Blood Vessels.
CGRP 通过促进骨血管分泌 ANGPTL4 来调节骨髓间充质干细胞,从而增强骨缺损的再生。
Mouse digit AAV gene delivery into fibroblasts regulates regenerative outcome.
将小鼠指状腺相关病毒(AAV)基因导入成纤维细胞可调节再生结果。
Many but not all pathogen-associated molecular patterns aggravate neurogenic heterotopic ossification after spinal cord injury.
许多(但并非所有)病原体相关分子模式会加剧脊髓损伤后的神经源性异位骨化。
Enhancing the Osseointegration of Titanium Implants by Modulating M1/M2 Macrophage Polarization through PI3K-Akt Signal Pathway on a "Cortex-like" Microarc Oxidation Coating.
通过PI3K-Akt信号通路调节M1/M2巨噬细胞极化,增强“皮质样”微弧氧化涂层上钛种植体的骨整合。
Abnormal mechanical load aggravates subchondral bone remodeling and uneven tibial plateau settlement in knee osteoarthritis via activation of osteoblast Piezo1-Ca²⁺-JAK2/STAT3 signaling
异常机械负荷通过激活成骨细胞 Piezo1-Ca²⁺-JAK2/STAT3 信号通路,加剧膝骨关节炎中的软骨下骨重塑和胫骨平台不均匀沉降。
IL-4/Nanohydroxyapatite Codelivery in a Dual-Bionic Scaffold: Design and Immunomodulatory Endogenous Osteogenesis Mechanism.
IL-4/纳米羟基磷灰石在双仿生支架中的共递送:设计和免疫调节内源性成骨机制。
- 1
- 2
- 3
- 4
- 5
- 6
- 22